Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score and Diabetic Neuropathy in Patients with Type 2 Diabetes Mellitus
Authors:
- 8 June 2026
- journal article
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 134 (10) , 338-343
Abstract
Background Diabetic neuropathy (DN) is a common microvascular complication of type 2 diabetes mellitus (T2DM), associated with chronic inflammation and metabolic dysregulation. The hemoglobin–albumin–lymphocyte–platelet (HALP) score is a composite index reflecting nutritional and inflammatory status, but its association with DN remains insufficiently characterized. Methods In this retrospective cross-sectional study, 212 patients with T2DM were evaluated. DN was defined using electrophysiological criteria. Multivariable logistic regression analysis was performed to assess the association between HALP and DN after adjustment for age, sex, diabetes duration, body mass index, and HbA1c. HALP was analyzed as a continuous variable (per 0.1-unit increase) and in quartiles. Receiver operating characteristic (ROC) curve analysis was used to evaluate model discrimination. Results Diabetic neuropathy was present in 45.2% of patients. HALP levels were significantly lower in patients with DN compared to those without DN (0.36 ± 0.18 vs. 0.72 ± 0.39, p < 0.001). In multivariable analysis, HALP remained independently associated with DN (OR per 0.1-unit increase: 0.46, 95% CI 0.35–0.58, p < 0.001). Quartile analysis showed a graded inverse association (p for trend < 0.001). The addition of HALP improved model discrimination compared to the base model (AUC 0.868 vs. 0.567). Conclusion HALP is inversely associated with diabetic neuropathy in patients with T2DM and may represent an integrated marker of metabolic and inflammatory burden.Keywords
This publication has 16 references indexed in Scilit:
- Association between Hemoglobin–albumin–lymphocyte–platelet score and all-cause or cardiovascular mortality in patients with diabetes or prediabetes: mediated effects of renal functionBMC Cardiovascular Disorders, 2025
- Diagnostic Value of HALP Score in Detecting Diabetic Nephropathy in Patients with Type 2 Diabetes MellitusIbnosina Journal of Medicine and Biomedical Sciences, 2024
- Relationship between neutrophil to lymphocyte ratio and diabetic peripheral neuropathy: a systematic review and meta-analysisEuropean Journal of Medical Research, 2023
- New perspectives in diabetic neuropathyNeuron, 2023
- What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer typesOncotarget, 2023
- Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review and meta-analysis of 13,110 patientsInternational Immunopharmacology, 2022
- Chronic tissue inflammation and metabolic diseaseGenes & Development, 2021
- Metabolic Inflammation and Insulin Resistance in ObesityCirculation Research, 2020
- Diabetic neuropathyNature Reviews Disease Primers, 2019
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007